EUVIMEDEUVIMED entdecken
Crossref

Utilization of a Postpartum Fasting Blood Glucose to Predict Impaired Glucose Tolerance in Patients with Gestational Diabetes Mellitus

Alissa K Prior iD, Cara D Dolin, Whitney Bender iD, Celeste P Durnwald, Rebecca F Hamm

American Journal of Perinatology · 01.04.2025 · 42 (06) · 708-712

DOI: 10.1055/a-2416-5742 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Perinatology, erschienen am 01.04.2025. Verfasst von Alissa K Prior und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, Pennsylvania. Hauptthemen laut MEDLINE: Diabetes, Gestational, Blood Glucose, Postpartum Period, Glucose Intolerance. Die Arbeit nennt 13 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The Endocrine Society recommends a postpartum fasting blood glucose (FBG) be performed for patients with gestational diabetes mellitus (GDM) prior to hospital discharge to screen for ongoing hyperglycemia. There are limited data, however, on whether an FBG can screen for glucose intolerance and if it correlates with the gold standard 4- to 12-week 2-hour oral glucose tolerance test (OGTT). Our objective was to evaluate if FBG correlates with the gold standard 2-hour OGTT. This retrospective cohort study of patients with GDM who delivered >20 weeks' gestation at two urban centers from January 2017 to December 2020 included those who completed both a postpartum FBG prior to discharge and a 2-hour 75-g OGTT within 1 year of delivery. Abnormal 2-hour OGTT was defined as fasting value ≥100 mg/dL and/or 2-hour value ≥140 mg/dL. We evaluated test characteristics (e.g., sensitivity, specificity) of postpartum FBG cut-offs to predict an abnormal 2-hour OGTT result. A total of 235 patients met inclusion criteria, of which 63% were diet-controlled and 37% required medical management. FBG ranged from 64 to 134 mg/dL, with 6/235 (2.6%) with values ≥126 mg/dL. A total of 39/235 (16.6%) of patients had an abnormal 2-hour OGTT. Overall, area under the curve for FBG predicting abnormal 2-hour OGTT was 0.65. Traditionally considered high cut-offs (≥126 mg/dL) for predicting persistent impaired glucose intolerance demonstrated poor positive predictive value (PPV; 90%). A postpartum FBG of 88 mg/dL was determined to be the optimal cut-off for FBG with NPV = 92.4% (Youden index = 0.34). In this dataset, if FBG ≥ 88 mg/dL was used to determine if 2-hour OGTT was required, almost half of GDM patients could avoid further glucose tolerance testing. While previously thought of as best utilized for its PPV, the FBG may be best used for its NPV. In our study, clinical application of an FBG < 88 mg/dL was highly correlative with a normal 2-hour OGTT.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes, GestationalBlood GlucosePostpartum PeriodGlucose IntoleranceFastingHumansFemalePregnancyRetrospective StudiesGlucose Tolerance TestAdultPredictive Value of TestsSensitivity and Specificity

Substanzen

Blood Glucose

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Pennsylvania Hospital, Philadelphia, Pennsylvania.
  • Department of Obstetrics and Gynecology, Case Western Reserve University School of Medicine, MetroHealth Medical Center, Cleveland, Ohio.
  • Department of Obstetrics and Gynecology, Case Western Reserve University School of Medicine, University Hospitals, Cleveland, Ohio.
  • Department of Obstetrics and Gynecology, Ob/Gyn and Women's Health Institute, Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio.
  • Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Division of Maternal Fetal Medicine, Department of Obstetrics and Gynecology, Virginia Commonwealth University School of Medicine, Richmond, Virginia.

ORCID-Profile: Alissa K Prior, Whitney Bender

Zitieren

APA

Prior, A. K., Dolin, C. D., Bender, W., Durnwald, C. P., & Hamm, R. F. (2025). Utilization of a Postpartum Fasting Blood Glucose to Predict Impaired Glucose Tolerance in Patients with Gestational Diabetes Mellitus. American Journal of Perinatology, 42(06), 708-712. https://doi.org/10.1055/a-2416-5742

Vancouver

Prior AK, Dolin CD, Bender W, Durnwald CP, Hamm RF. Utilization of a Postpartum Fasting Blood Glucose to Predict Impaired Glucose Tolerance in Patients with Gestational Diabetes Mellitus. American Journal of Perinatology. 2025;42(06):708-712. doi:10.1055/a-2416-5742

BibTeX
@article{Prior2025,
  author = {Prior, Alissa K and Dolin, Cara D and Bender, Whitney and Durnwald, Celeste P and Hamm, Rebecca F},
  title = {Utilization of a Postpartum Fasting Blood Glucose to Predict Impaired Glucose Tolerance in Patients with Gestational Diabetes Mellitus},
  journal = {American Journal of Perinatology},
  year = {2025},
  volume = {42},
  number = {06},
  pages = {708--712},
  doi = {10.1055/a-2416-5742}
}
Kostenlos starten →